Top of this page
Skip navigation, go straight to the content

UCB - The next generation biopharma leader

close Choose a text size

CDP323

Therapeutic focus

Multiple Sclerosis

Type of molecule

NCE (small molecule)

Mode of action

Alpha-4 integrin antagonist

Partner

Biogen Idec (http://www.biogenidec.com/)